La Fleur & Godfrey LLC Organon & Co. Transaction History

La Fleur & Godfrey LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 26, 2022	SELL	$31.66 - $38.9 $232,732 - $285,953	-7,351 Closed	0 $0
Q1 2022 May 03, 2022	SELL	$30.45 - $39.36 $33,038 - $42,705	-1,085 Reduced 12.86%	7,351 $257,000
Q4 2021 Jan 26, 2022	SELL	$28.67 - $37.13 $53,612 - $69,433	-1,870 Reduced 18.14%	8,436 $257,000
Q3 2021 Nov 01, 2021	SELL	$28.63 - $35.64 $135,505 - $168,684	-4,733 Reduced 31.47%	10,306 $338,000
Q2 2021 Jul 19, 2021	BUY	$28.45 - $38.0 $427,859 - $571,482	15,039 New	15,039 $453,000

793

192M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.75B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of La Fleur & Godfrey LLC, based on Form 13F filings with the SEC.

Stay updated on La Fleur & Godfrey LLC with notifications on news.